Betterlife Pharma Inc
(BETRF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 01/31
| 01-2022 | 10-2021 | 07-2021 | 04-2021 | 01-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,709 | -6,542 | -4,895 | -1,941 | -27,201 |
| Depreciation Amortization | 15 | 11 | 8 | 4 | 257 |
| Accounts receivable | 145 | 349 | 338 | 308 | -262 |
| Other Working Capital | -1,051 | -1,153 | -1,184 | -335 | -1,156 |
| Other Operating Activity | 1,655 | -30 | -67 | -310 | 23,001 |
| Operating Cash Flow | $-8,946 | $-7,365 | $-5,800 | $-2,275 | $-5,362 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -8 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 19 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -65 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -65 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-54 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 96 | -104 | 98 | 95 | 449 |
| Debt Repayment | -200 | N/A | -106 | N/A | N/A |
| Common Stock Issued | 9,135 | 9,104 | 9,313 | 2,353 | 2,985 |
| Other Financing Activity | -62 | -61 | -161 | -61 | -374 |
| Financing Cash Flow | $8,970 | $8,940 | $9,144 | $2,387 | $3,060 |
| Exchange Rate Effect | -10 | 1 | -13 | -17 | 15 |
| Beginning Cash Position | 124 | 123 | 126 | 123 | 2,456 |
| End Cash Position | 139 | 1,698 | 3,457 | 218 | 116 |
| Net Cash Flow | $15 | $1,575 | $3,331 | $95 | $-2,340 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,946 | -7,365 | -5,800 | -2,275 | -5,362 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -8 |
| Free Cash Flow | -8,946 | -7,365 | -5,800 | -2,275 | -5,369 |